Bioengineered
Volume 13, 2022 - Issue 2
Open access
1,325
Views
4
CrossRef citations to date
0
Altmetric
Research Paper
Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer
Xuemei Liua Department of Gynaecology and Obstetrics, Jinan City People’s Hospital, Jinan, ChinaView further author information
, Zhiping Yinb Department of Laboratory Medicine, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, ChinaView further author information
, Yanjun Wuc Department of Gynaecology and Obstetrics, Liaocheng People’s Hospital, Liaocheng, ChinaView further author information
, Qian Zhanb Department of Laboratory Medicine, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, ChinaView further author information
, Honghong Huangd Department of Pharmacy, Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6741-9664View further author information
Jiangtao Fane Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 3739-3750
|
Received 09 Dec 2021, Accepted 08 Jan 2022, Published online: 26 Jan 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.